TABLE 1.
Antimicrobial susceptibility profiles of the blaVIM-2-carrying Pseudomonas sp. isolates
| Antimicrobial agent | MIC (μg/ml)
|
|||
|---|---|---|---|---|
| P. fluorescens 43-14926 |
P. aeruginosa
|
|||
| 49-4583 | 49-4596 | 49-4597 | ||
| β-Lactams | ||||
| Cefazolin | >16 | >16 | >16 | >16 |
| Cefoxitin | >32 | >32 | >32 | >32 |
| Aztreonam | >16 | >16 | 16 | 16 |
| Cefuroxime | >16 | >16 | >16 | >16 |
| Ceftriaxone | >32 | >32 | >32 | >32 |
| Ceftazidime | >16 | >16 | >16 | >16 |
| Cefepime | 16 | >16 | >16 | >16 |
| Imipenem | >8 | >8 | >8 | >8 |
| Meropenem | >8 | >8 | >8 | >8 |
| Piperacillin-tazobactam | >64 | 64 | 64 | 64 |
| Quinolones | ||||
| Ciprofloxacin | >4 | >4 | >4 | >4 |
| Gatifloxacin | >4 | >4 | >4 | >4 |
| Levofloxacin | >4 | >4 | >4 | >4 |
| Aminoglycosides | ||||
| Amikacin | 8 | >32 | >32 | >32 |
| Gentamicin | >8 | >8 | >8 | >8 |
| Netilmicin | >32 | >32 | >32 | >32 |
| Tobramycin | >16 | >16 | >16 | >16 |
| Others | ||||
| Polymyxin B | ≤1 | ≤1 | ≤1 | ≤1 |
| Tetracycline | >8 | >8 | >8 | >8 |
| Trimethoprim-sulfamethoxazole | >2 | >2 | >2 | >2 |